Brian D. Guth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Brian D. Guth has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Sabine Tacke
Clinic for Small Animals (Surgery), Faculty of Veterinary Medicine, Justus-Liebig-University, Frankfurter Street 114, 35392 Giessen, Germany
3 shared publications - Anne Grobler
DST/NWU Preclinical Drug Development Platform, North-West University, Potchefstroom, 2520, South Africa
2 shared publications - Julia Henke
Department of Nonclinical Drug Safety, Biological Laboratory Service, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach, Germany.
2 shared publications Michael K. Pugsley
Safety Pharmacology Society, Fairfield, CT, USA
2 shared publications- Michael Markert
Department of Drug Discovery Sciences, General Pharmacology Group, Boehringer Ingelheim Pharma GmbH & Co KG, Germany
2 shared publications A.S. Bass
1 shared publication
Latest Publications
- Open Access
- 1 July 2019
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 98, 106579
Drug safety Africa: An overview of safety pharmacology & toxicology in South Africa
- 1 July 2019
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 98, 106579
Open AccessDrug safety Africa: An overview of safety pharmacology & toxicology in South Africa
- 1 September 2018
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 93, 26-28
Safety pharmacology in and for Africa: Establishment of the pre-clinical drug development platform
- 1 September 2018
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 93, 26-28
Safety pharmacology in and for Africa: Establishment of the pre-clinical drug development platform
- 1 September 2017
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 87, 24-26
GLP in safety pharmacology studies: Report card after 15 years
- 1 September 2017
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 87, 24-26
GLP in safety pharmacology studies: Report card after 15 years
- Open Access
- 1 July 2016
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 80, 9-18
Successful implantation of an abdominal aortic blood pressure transducer and radio-telemetry transmitter in guinea pigs — Anaesthesia, analgesic management and surgical methods, and their influence on hemodynamic parameters and body temperature
- 1 July 2016
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 80, 9-18
Open AccessSuccessful implantation of an abdominal aortic blood pressure transducer and radio-telemetry transmitter in guinea pigs — Anaesthesia, analgesic management and surgical methods, and their influence on hemodynamic parameters and body temperature
- Open Access
- 31 December 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 1-15
Influence of repeated anaesthesia on physiological parameters in male Wistar rats: a telemetric study about isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl
This study evaluated the influence of repeated anaesthesia using isoflurane (ISO, 2–3 Vol%), ketamine-xylazine (KX, 100 mg·kg−1 + 5 mg·kg−1, i.m.) or a combination of medetomidine-midazolam-fentanyl (MMF, 0.15 mg·kg−1 + 2.0 mg·kg−1 + 0.005 mg·kg−1, i.m.) on heart rate (HR), arterial blood pressure (BP), body temperature (BT), duration of anaesthetic intervals and body weight (BW) in Wistar rats. Rats were instrumented with a telemetric system for the measurement of systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), pulse pressure (PP), HR and BT during induction, maintenance and recovery of anaesthesia. Each anaesthesia was performed six times within three weeks. KX was not antagonized, but ISO delivery was terminated 40 minutes after induction and MMF was reversed with atipamezole-flumazenil-naloxone (AFN, 0.75 mg·kg−1 + 0.2 mg·kg−1 + 0.12 mg·kg−1, s.c.). With repeated anaesthesia, ISO showed a decrease of HR and BP. A significant decrease of PP could be observed with repeated anaesthesia using MMF. HR and BP were not affected by repeated KX anaesthesia, but we noted a reduction of sleeping time and BW. Neither MMF nor ISO showed significant differences in the duration of anaesthetic intervals and BW. With KX we observed tissue necrosis at the injection site and surgical tolerance was not achieved in 25% of the anaesthesias performed. HR, BP values, BT, duration of anaesthetic intervals and BW were affected differently by repeated anaesthesia performed with ISO, KX or MMF. ISO produced a reproducible anaesthesia, thereby being suitable for repeated use, but with a decrease of HR and BP throughout the six anaesthesias. The use of ISO in cases where these parameters should be unaffected is therefore not advised. The inability to produce a surgical tolerance, the reduction of sleeping time and BW, as well as the tissue necrosis are significant contraindications for a repeated use of KX. Only mild changes of BP were found with repeated MMF anaesthesia, so it seems suitable for serial use, unless the high BP and the low HR during the surgical plane of anaesthesia are undesirable for a special procedure.
- 31 December 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 1-15
Open AccessInfluence of repeated anaesthesia on physiological parameters in male Wistar rats: a telemetric study about isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl
This study evaluated the influence of repeated anaesthesia using isoflurane (ISO, 2–3 Vol%), ketamine-xylazine (KX, 100 mg·kg−1 + 5 mg·kg−1, i.m.) or a combination of medetomidine-midazolam-fentanyl (MMF, 0.15 mg·kg−1 + 2.0 mg·kg−1 + 0.005 mg·kg−1, i.m.) on heart rate (HR), arterial blood pressure (BP), body temperature (BT), duration of anaesthetic intervals and body weight (BW) in Wistar rats. Rats were instrumented with a telemetric system for the measurement of systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), pulse pressure (PP), HR and BT during induction, maintenance and recovery of anaesthesia. Each anaesthesia was performed six times within three weeks. KX was not antagonized, but ISO delivery was terminated 40 minutes after induction and MMF was reversed with atipamezole-flumazenil-naloxone (AFN, 0.75 mg·kg−1 + 0.2 mg·kg−1 + 0.12 mg·kg−1, s.c.). With repeated anaesthesia, ISO showed a decrease of HR and BP. A significant decrease of PP could be observed with repeated anaesthesia using MMF. HR and BP were not affected by repeated KX anaesthesia, but we noted a reduction of sleeping time and BW. Neither MMF nor ISO showed significant differences in the duration of anaesthetic intervals and BW. With KX we observed tissue necrosis at the injection site and surgical tolerance was not achieved in 25% of the anaesthesias performed. HR, BP values, BT, duration of anaesthetic intervals and BW were affected differently by repeated anaesthesia performed with ISO, KX or MMF. ISO produced a reproducible anaesthesia, thereby being suitable for repeated use, but with a decrease of HR and BP throughout the six anaesthesias. The use of ISO in cases where these parameters should be unaffected is therefore not advised. The inability to produce a surgical tolerance, the reduction of sleeping time and BW, as well as the tissue necrosis are significant contraindications for a repeated use of KX. Only mild changes of BP were found with repeated MMF anaesthesia, so it seems suitable for serial use, unless the high BP and the low HR during the surgical plane of anaesthesia are undesirable for a special procedure.
- Open Access
- 23 August 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 198
Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats
This study investigated effects on cardiovascular parameters during anaesthesia with isoflurane (ISO, 2–3 Vol%), ketamine-xylazine (KX, 100 mg•kg−1 + 5 mg•kg−1) or a combination of medetomidine-midazolam-fentanyl (MMF, 0.15 mg•kg−1 + 2.0 mg•kg−1 + 0.005 mg•kg−1) in rats throughout induction, maintenance and recovery from anaesthesia. Rats were instrumented with a telemetric system for the measurement of systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), pulse pressure (PP), heart rate (HR) and core body temperature (BT). The parameters were continuously measured before, during and after each type of anaesthesia. Forty minutes after induction, ISO delivery was terminated and MMF was antagonized with atipamezole-flumazenil-naloxone (AFN, 0.75 mg•kg−1 + 0.2 mg•kg−1 + 0.12 mg•kg−1) whereas KX was not antagonized.
- 23 August 2014
- Published by Springer Nature in BMC Veterinary Research
- Vol. 10 (1) , 198
Open AccessEffects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats
This study investigated effects on cardiovascular parameters during anaesthesia with isoflurane (ISO, 2–3 Vol%), ketamine-xylazine (KX, 100 mg•kg−1 + 5 mg•kg−1) or a combination of medetomidine-midazolam-fentanyl (MMF, 0.15 mg•kg−1 + 2.0 mg•kg−1 + 0.005 mg•kg−1) in rats throughout induction, maintenance and recovery from anaesthesia. Rats were instrumented with a telemetric system for the measurement of systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), pulse pressure (PP), heart rate (HR) and core body temperature (BT). The parameters were continuously measured before, during and after each type of anaesthesia. Forty minutes after induction, ISO delivery was terminated and MMF was antagonized with atipamezole-flumazenil-naloxone (AFN, 0.75 mg•kg−1 + 0.2 mg•kg−1 + 0.12 mg•kg−1) whereas KX was not antagonized.
- 1 September 2009
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 60 (2) , 107-116
Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies
- 1 September 2009
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 60 (2) , 107-116
Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies
- 1 January 2007
- Published by Springer Nature in International Journal of Pharmaceutical Medicine
- Vol. 21 (5) , 357-361
Safety Pharmacology Assessment
- 1 January 2007
- Published by Springer Nature in International Journal of Pharmaceutical Medicine
- Vol. 21 (5) , 357-361
Safety Pharmacology Assessment